Cooper Financial Group Medpace Holdings, Inc. Transaction History

Cooper Financial Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$138.87 - $214.31 $269,268 - $415,547	-1,939 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$182.74 - $227.9 $2,923 - $3,646	-16 Reduced 0.82%	1,939 $422,000
Q3 2021 Oct 06, 2021	BUY	$170.18 - $198.21 $23,995 - $27,947	141 Added 7.77%	1,955 $370,000
Q2 2021 Jul 12, 2021	BUY	$158.62 - $194.3 $25,537 - $31,282	161 Added 9.74%	1,814 $320,000
Q1 2021 May 17, 2021	SELL	$132.02 - $168.26 $30,232 - $38,531	-229 Reduced 12.17%	1,653 $271,000
Q4 2020 Feb 16, 2021	BUY	$109.38 - $149.19 $205,853 - $280,775	1,882 New	1,882 $262,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

Stay updated on Cooper Financial Group with notifications on news.